{"title":"Primary peritoneal serous carcinoma","authors":"A. Ilancheran, Joesph Ng Soon Yau","doi":"10.1016/j.rigp.2003.12.004","DOIUrl":null,"url":null,"abstract":"<div><p>Primary peritoneal serous carcinoma (PPSC), also commonly called primary peritoneal cancer, often presents with clinical features identical to advanced epithelial ovarian carcinoma (EOC). The diagnosis is made only after a laparotomy. The main differentiating feature is advanced peritoneal involvement with tumour without gross involvement of the ovaries. In the absence of any randomised trials, the management of PPSC is very similar to that of EOC, with primary debulking surgery and adjuvant chemotherapy. The prognosis appears to be related to the volume of residual disease, with minimal disease providing a longer disease free interval.</p></div>","PeriodicalId":101089,"journal":{"name":"Reviews in Gynaecological Practice","volume":"4 2","pages":"Pages 89-92"},"PeriodicalIF":0.0000,"publicationDate":"2004-06-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://sci-hub-pdf.com/10.1016/j.rigp.2003.12.004","citationCount":"3","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Reviews in Gynaecological Practice","FirstCategoryId":"1085","ListUrlMain":"https://www.sciencedirect.com/science/article/pii/S1471769703001436","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
引用次数: 3
Abstract
Primary peritoneal serous carcinoma (PPSC), also commonly called primary peritoneal cancer, often presents with clinical features identical to advanced epithelial ovarian carcinoma (EOC). The diagnosis is made only after a laparotomy. The main differentiating feature is advanced peritoneal involvement with tumour without gross involvement of the ovaries. In the absence of any randomised trials, the management of PPSC is very similar to that of EOC, with primary debulking surgery and adjuvant chemotherapy. The prognosis appears to be related to the volume of residual disease, with minimal disease providing a longer disease free interval.
求助内容：
应助结果提醒方式：
京公网安备 11010802042870号
